Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma'. Together they form a unique fingerprint.